Question 1

What is Sana Biotechnology's total liabilities & equity?

Accepted Answer

Sana Biotechnology (SANA) reported total liabilities & equity of $373.59M in Q1 2026.

Question 2

How has Sana Biotechnology's total liabilities & equity changed year-over-year?

Accepted Answer

Sana Biotechnology's total liabilities & equity decreased by 16.1% year-over-year, from $445.47M to $373.59M.

Question 3

What is the long-term trend for Sana Biotechnology's total liabilities & equity?

Accepted Answer

Over 5 years (2020 to 2025), Sana Biotechnology's total liabilities & equity has grown at a -10.6% compound annual growth rate (CAGR), from $730.3M to $416.89M.

Question 4

What does total liabilities & equity mean?

Accepted Answer

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Line item	March 31, 2026	December 31, 2025
Stockholders' equity:
Preferred stock, $0.0001 par value; 50,000 shares authorized; zero shares issued and outstanding as of March 31, 2026 and December 31, 2025	-	-
Common stock, $0.0001 par value; 750,000 shares authorized; 269,817 and 266,732 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	27	27
Additional paid-in capital	2,015,441	2,009,845
Accumulated other comprehensive income (loss)	(2)	28
Accumulated deficit	(1,896,226)	(1,849,016)
Total stockholders' equity	119,240	160,884
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$373,593	$416,890

Total Liabilities & Equity at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Sana Biotechnology's total liabilities & equity.

Sana Biotechnology SANA Total Liabilities & Equity